Ali, D.A.; Sabry, N.M.; Kabel, A.M.; Gaber, R.A.; Mokhtar, H.M.; Samy, S.M.; Elrashidy, M.A.; Salama, S.A.; Abdelhai, D.
The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival. Medicina 2021, 57, 866.
https://doi.org/10.3390/medicina57090866
AMA Style
Ali DA, Sabry NM, Kabel AM, Gaber RA, Mokhtar HM, Samy SM, Elrashidy MA, Salama SA, Abdelhai D.
The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival. Medicina. 2021; 57(9):866.
https://doi.org/10.3390/medicina57090866
Chicago/Turabian Style
Ali, Dina A., Nesreen M. Sabry, Ahmed M. Kabel, Rasha A. Gaber, Hwaida M. Mokhtar, Sara M. Samy, Mohamed A. Elrashidy, Samir A. Salama, and Dina Abdelhai.
2021. "The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival" Medicina 57, no. 9: 866.
https://doi.org/10.3390/medicina57090866
APA Style
Ali, D. A., Sabry, N. M., Kabel, A. M., Gaber, R. A., Mokhtar, H. M., Samy, S. M., Elrashidy, M. A., Salama, S. A., & Abdelhai, D.
(2021). The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival. Medicina, 57(9), 866.
https://doi.org/10.3390/medicina57090866
